A Prospective 1-Year Follow-Up of Glycemic Status and C-Peptide Levels of COVID-19 Survivors with Dysglycemia in Acute COVID-19 Infection

CONCLUSION: Subjects who had dysglycemia in acute COVID-19 were characterized by insulin resistance. Over 1 year, a quarter had progression in glycemic status, especially those with more severe COVID-19. Importantly, there was no significant deterioration in insulin secretory capacity.PMID:38467385 | DOI:10.4093/dmj.2023.0175
Source: Diabetes and Metabolism Journal - Category: Endocrinology Authors: Source Type: research